| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 8 |
| 1 | FEXOFENADINE | 5 |
| 2 | LEFLUNOMIDE | 5 |
| 3 | METHOTREXATE | 5 |
| 4 | METHOTREXATE SODIUM | 5 |
| 5 | MYCOPHENOLATE MOFETIL | 5 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 5 |
| 7 | HYDROXYCHLOROQUINE | 3 |
| 8 | MORPHINE SULFATE | 3 |
| 9 | ADALIMUMAB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUOROMETHOLONE ACETATE | 1 | 0.0037 |
| 1 | PENICILLIN G POTASSIUM | 1 | 0.0014 |
| 2 | ROPEGINTERFERON ALFA-2B | 1 | 0.0005 |
| 3 | PENICILLIN G | 1 | 0.0004 |
| 4 | DEFLAZACORT | 1 | 0.0004 |
| 5 | RISDIPLAM | 1 | 0.0002 |
| 6 | KETOTIFEN FUMARATE | 1 | 0.0002 |
| 7 | BETAMETHASONE DIPROPIONATE | 1 | 0.0001 |
| 8 | ACETAMINOPHEN, ASPRIN, CAFFEINE | 1 | 0.0001 |
| 9 | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 8 |
| 1 | Corticosteroid [EPC] | 6 |
| 2 | Antirheumatic Agent [EPC] | 5 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 5 |
| 4 | Benzodiazepine [EPC] | 3 |
| 5 | Anti-IgE [EPC] | 2 |
| 6 | Janus Kinase Inhibitor [EPC] | 2 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 8 | Opioid Agonist [EPC] | 2 |
| 9 | Vitamin B12 [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 1 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 2 | Antirheumatic Agent [EPC] | 5 | 0.0000 |
| 3 | Progesterone [EPC] | 1 | 0.0000 |
| 4 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 5 | Anti-IgE [EPC] | 2 | 0.0000 |
| 6 | Folate Analog [EPC] | 1 | 0.0000 |
| 7 | Vitamin A [EPC] | 1 | 0.0000 |
| 8 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 9 | Methylxanthine [EPC] | 1 | 0.0000 |